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Summary
Background.— Thrombus straddling the patent foramen ovale (TSFO) is a rare event. It occurs
in the presence of pulmonary embolism and can be responsible for paradoxical embolism. The
aim of this report is to guide the optimal choice of treatment for TSFO in different clinical
contexts.
Methods.— A PubMed search was conducted of articles published between 1985, when the ﬁrst
TSFO was reported, and 2007. We identiﬁed 93 cases of TSFO diagnosed by echocardiography,
nine of which were excluded because of lack of information. We analysed data from these
84 patients plus a further four seen at three French cardiology departments.
Results.— The patients’ mean age was 58 years. Pulmonary embolism was present in 94% of
cases, and was severe in 34%. Paradoxical embolism, before or after treatment, was found in
44% of cases.
@wanadoo.fr (E. Fauveau).
2008 Elsevier Masson SAS. All rights reserved.
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surgical group. Surgery seems to be justiﬁed in the prevention of paradoxical embolism. Throm-
bolysis is more frequently chosen in the higher risk group and is associated with the greatest
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cardiaque
des patients plus âgés présentant des comorbidités. Cependant, la mortalité est similaire dans
cette revue entre le groupe chirurgie et le groupe héparine. La chirurgie semble justiﬁé en
prévention du risque d’embolie paradoxale. La thrombolyse choisie chez les patients les plus
s for
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eports of thrombus straddling the patent foramen ovale
TSFO) are rare. In the presence of systemic embolism, the
iagnosis of paradoxical embolism is certain when TSFO is
ound. In 1985, Nellessen et al. [1] reported the ﬁrst clinical
ase diagnosed by echocardiography. Despite the advent of
his technique, TSFO is still rarely diagnosed and its ther-
peutic management remains unclear. Therapeutic options
nclude surgical treatment with thrombectomy or medical
reatment with heparin or thrombolysis.
We report four cases of TSFO diagnosed by echocardio-
raphy in three French cardiology departments: two were
reated with surgery and two with anticoagulation. In addi-
ion, through a PubMed search, we identiﬁed 93 published
ases of TSFO, nine of which were excluded as they did
ot include precise data. We analysed the clinical presenta-
ions, paraclinical examinations, treatments and outcomes
f these 88 cases.
a
t
a
lte mortalité.
rights reserved.
ase 1
n obese (body mass index 40 kg/m2) 50-year-old woman
omplained of dyspnoea with desaturation (88% in ambi-
nt air) and collapsus, 3 days after knee ligamentoplasty.
ower limb venous echo-Doppler described bilateral venous
hrombosis. Spiral computed pulmonary tomography found
roximal bilateral pulmonary embolism (PE). The patient
nitially received intravenous thrombolysis associated with
nfractionated heparin treatment. Transthoracic echocar-
iography (TTE) conducted the following day revealed a
obile thrombus 4 cm long entrapped in a patent foramen
vale (PFO) (Fig. 1), which prolapsed into the right ventricle.
he right cavities were dilated. She was transferred, as an
mergency, to a cardiac surgical centre for thrombectomyE. Fauveau et al.
Fifty-ﬁve patients were treated surgically, 21 were treated with heparin, and 11 received throm-
bolysis. The mortality rates for the treatments were 13, 14 and 36%, respectively. Patients who
received heparin were older (60± 17 years) and had more strokes (11/21) than the surgical
group (56± 15 years, 14/55). The group that received thrombolysis was more likely to have
haemodynamic compromise.
Conclusion.— Medical treatment with heparin tends to be used as a second option in patients
with more frequent comorbidities and strokes but the mortality rate is similar to that in themortality.
© 2008 Elsevier Masson SAS. All rights reserved.
Résumé
Objectifs.— Entité rare, le thrombus enclavé dans le foramen ovale (TEFO) s’observe
habituellement dans un contexte d’embolie pulmonaire sévère et/ou d’embolie paradoxale.
La conduite thérapeutique n’est pas établie. L’objet de ce travail est de préciser les élé-
ments pouvant guider le choix de la stratégie thérapeutique dans cette circonstance rare mais
grave.
Méthodes.— La recherche bibliographique PubMed de 1985 à 2007 a permis de sélectionner les
observations de TEFO diagnostiqué, avant toute décision thérapeutique : 93 patients ont été
identiﬁés. Neuf cas ont été exclus de l’analyse pour manque de données. L’analyse a porté sur
88 patients incluant les quatre patients de notre série personnelle.
Résultats.— L’âge moyen de la population étudiée était de 58 ans. Les données cliniques étaient
les suivantes : diagnostic d’embolie pulmonaire dans 94 % des cas, dont 34 % avec signes de
gravité clinique. Une embolie paradoxale était retrouvée dans 44 % des cas. Cinquante-cinq cas
ont été traités chirurgicalement, 21 ont rec¸u un traitement par héparine et 11 ont été traités
par thrombolyse. La mortalité précoce était respectivement dans les trois groupes 13, 14 et
36 %.
Le sous-groupe héparine se caractérisait par un âge moyen élevé (60± 17 ans), un taux d’AVC
important (11/21) par comparaison au sous-groupe chirurgie, d’âge moyen 56± 15 ans, et avec
un taux d’AVC faible (14/55). Les patients traités par thrombolyse présentaient plus souvent
des états hémodynamiques précaires.
Conclusion.— Le traitement médical par héparine est le plus souvent choisi par défaut chezssociated with closure of the PFO and pulmonary embolec-
omy (Fig. 2). Abdominal and cerebral scanning did not ﬁnd
ny paradoxical embolism. The patient is doing well 2 years
ater, on prolonged anticoagulation treatment.
Surgical or medical treatment for thrombus straddling the patent foramen ovale 639
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graphy, long axis view.
Case 2
An 86-year-old man was hospitalized for chest pain com-
bined with lipothymia and dyspnoea, a few days after
hospitalization for urinary septicaemia. Clinical examination
found a blood pulse of 120/min, normal arterial blood pres-
sure (120/70mmHg) and signs of clinical right heart failure.
Lung scintigraphy concluded that there was a high proba-
bility of PE. TTE described dilated right cavities, paradoxal
septum, arterial pulmonary hypertension of 70mmHg and a
serpentine and mobile thrombus in the left atrium. Tran-
soesophageal echocardiography (TEE) showed a thrombus
entrapped in the PFO (Fig. 3). Lower limb venous echo-
Doppler described bilateral venous thrombosis. A cerebral
scan was normal. Treatment with hypocoagulant unfraction-
ated heparin was started, relayed by oral anticoagulation.
TEE, conducted after 7 days of treatment, showed persis-
tent thrombus entrapped in the PFO but reduced in size and
with a decreased arterial pulmonary pressure of 40mmHg.
After 15 days, the thrombus had disappeared. The patient’s
long-term outcome was favourable at 3 years.
Case 3A 73-year-old man was hospitalized for syncopa and dys-
pnoea. His medical history included cardiac surgery with
coronary bypass and mitral annuloplasty after myocardial
infarct, pulmonary tuberculosis, hypertension and dyslip-
Figure 2. Thrombus entrapped in PFO, anatomo-pathology piece.
d
c
h
e
c
b
t
p
n
M
A
a
digure 3. Thrombus entrapped in PFO, transoesophaeal echocar-
iography.
daemia. Clinical examination found a blood pressure of
00/70mmHg, a pulse rate of 96/min and moderate clin-
cal signs of right heart failure. A pulmonary CT scan
escribed bilateral PE associated with mural thrombosis of
he descending aorta. TTE showed pulmonary hypertension
f 46mmHg and right ventricle enlargement. TEE was done
o explore aorta thrombosis and revealed a thrombus long
f 2.6 cm, trapped in the PFO. The descending aorta was
ilated without signs of dissection. Lower limb venous echo-
oppler showed a right femoral thrombosis. Anticoagulant
reatment was started. TTE control after 7 days revealed
o remaining atrial thrombus. Abdominal and cerebral CT
can showed no paradoxical embolism. TEE performed after
days of anticoagulant treatment conﬁrmed that the TSFO
ad disappeared, and showed a PFO with colour Doppler.
he patient was discharged on oral anticoagulation and
emained symptom free over 1 year of follow-up.
ase 4
74-year-old man was admitted for an acute ischaemic left
eg and dyspnoea. Emergent echo-Doppler visualized com-
lete thrombotic occlusion of the femoral artery associated
ith femoral venous thrombosis. The leg was amputated
ecause of severe left leg ischaemia. TTE, performed a few
ays after the intervention because he remained dyspnoeic,
emonstrated a TSFO that had prolapsed through the tri-
uspid valve into the right ventricle, which was dilated and
ypokinetic. CT scan pulmonary angiography showed bilat-
ral proximal PE. Emergency thromboembolectomy under
ardiopulmonary bypass was performed. A 16 cm long throm-
us, which crossed the interatrial septum, was removed and
he PFO closed by direct suture. The patient had an uncom-
licated postoperative course, but a long readaptation was
ecessary because of the left leg amputation.ethods
PubMed search of the literature published between 1985
nd 2007 was conducted using the search terms ‘para-
oxical embolism’ OR ‘impending paradoxical embolism’
6 E. Fauveau et al.
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R ‘thrombus straddling patent foramen ovale’ without
anguage restriction. We also searched the reference lists
f retrieved articles to identify any additional studies. We
elected only cases of TSFO diagnosed by echocardiography
efore surgery and with thrombus entrapped in the PFO
learly visualized. Two literature reviews on TSFO were
ublished in 1998 by Meacham et al. [2] and Aboyans et
l. [3], which reported 30 and 43 cases, respectively. In
003, Chow et al. [4] published a review of impending
aradoxical embolism but included cases of TSFO diagnosed
uring surgery or postmortem, which were excluded from
ur review. We found a total of 93 cases of TSFO [1—32].
We reviewed the available data concerning the clinical
haracteristics, paraclinical examinations, treatments and
utcomes for all cases. Most were published in case-report
ormat, but the descriptions were not always very speciﬁc.
ome cases were reported only in letters or as images. Nine
ere included in reviews of impending paradoxical embolism
r intracardiac thrombus, and failed to include any details
oncerning TSFO, or the data were in languages that we
ere unable to translate, and were therefore excluded from
ur review [8,11,28,33,34]. The study population therefore
omprised 88 cases of TSFO, 84 from the literature and four
een at our institutions.
esults
he clinical characteristics are summarized in Table 1.
he clinical presentations were non-speciﬁc. TSFO was
iagnosed in the context of thromboembolic disease or
ystemic embolism. We found risk factors for venous
hromboembolism in 47 patients, including recent surgery,
ospitalization, progressive cancer, coagulation disturbance
r systemic disease (e.g., lupus, antiphospholipid syndrome,
rotein S deﬁciency) and other medical conditions such
s dehydration, obesity, renal polycystosis, immobiliza-
ion and an association between oral contraception and
obacco. The most frequently reported symptoms were,
n descending order, dyspnoea, tachycardia, chest pain,
ypotension, syncope or lipothymia, shock, hepatojugular
eﬂux or venous jugular turgescence, cyanosis, auricular ﬁb-
illation and haemoptysis. Clinical signs of severe pulmonary
mbolism, including syncope, collapsus, shock and cardiac
rrest, were present in 30 patients. Seventeen patients had
ardiogenic shock or cardiac arrest. Almost half of the
atients presented with an association between PE and
ystemic embolism (36/88 patients) before treatment. Two
ases of paradoxical embolism occurred after treatment
4,35]. The most frequent site of systemic embolism was
erebral, including four transient ischaemic attacks and
2 ischaemic strokes. Other sites of systemic embolism were
he inferior or superior limbs, kidneys, coronary arteries
nd spleen. Eight patients had multiple emboli in different
reas.
The types of paraclinical examinations performed to con-
rm the presence of PE were detailed in 50 patients, with
ung perfusion/ventilation scintigraphy in 34 cases (until
996) and lung spiral CT in 16 patients. Venous thrombosis
as documented in 47 patients by venous echo-Doppler.
All patients underwent echocardiographic diagnosis of
he thrombus entrapped in the PFO. For 26 patients the TSFO
a
F
4
w
rigure 4. Proportion of different treatment and outcome n = 88.
as clearly visible on TTE, but for the majority of patients
t was visible only by TEE (56 patients). These TEE were
erformed after TTE in order to diagnose accurately the
ntracardiac thrombus visualized by TTE for the majority of
ndividuals (28 cases). More frequently, the clot was seen on
TE in the right atrium (24 cases), but sometimes associated
ith other locations such as the left atrium (four cases),
nferior vena cava, right ventricle (two cases) or in the four
hambers of the heart. For two patients, TEE was performed
fter identiﬁcation of a left atrial thrombus, without any
hrombus identiﬁed in the right chambers by TTE. Others
ases of TSFO diagnosis on TEE were:
diagnosis of paradoxical embolism after systemic
embolism in eight patients;
TEE in ventilated patients performed for severe PE who
could not undergo TTE;
clinical worsening in the context of PE in two cases;
suspicion of aortic dissection in two cases.
For 14 patients, the indication of TEE was not detailed. In
ost cases, the thrombus was described as long, extremely
obile, snake-like or serpentine and often prolapsing into
he right and left ventricle through the tricuspid or mitral
alves. Sometimes it was visualized in the inferior vena cava
r prolapsing through the aortic valve.
The right ventricle was described in 35 cases, always
ilated. Pulmonary pressure was detailed for 28 patients,
nd was on average 60± 14mmHg (range 40—100). Infor-
ation on the type of treatment chosen was available
or 88 patients (Table 2). All patients were anticoagulated
xcept for one who was treated with an isolated inferior
ena cava ﬁlter because of a recent cerebral haemorrhage
35]. Twenty-one patients were treated with anticoagulants
lone (heparin relayed by a vitamin K antagonist). Throm-
olysis was administered in 13 (18%) patients, two of whom
ubsequently underwent surgical treatment (Fig. 4). The
rst patient was operated on because of failure of throm-
olysis [7]; the second patient was Case 1 (detailed earlier).
wo patients [4,36] received thrombolytic treatment despite
diagnosis of paradoxical embolism, including one stroke.
ifty-ﬁve patients ﬁnally underwent emergency surgery; in
4 of these cases the type of surgery was detailed. Surgery
as associated with cardiac thrombectomy on extracorpo-
eal circulation with closure of the PFO. In 17 of 44 cases
Surgicalor
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Table 1 TSFO population: demographics, clinical characteristics and paraclinical examination.
Patients Total population (n = 88) Treatment approach
Surgery (n = 55) Heparin (n = 21) Thrombolysis (n = 11) Vena cava ﬁlter (n = 1)
Men/women 37/48 32/18 10/10 5/5 1/0
Mean age, years (SD) 58 (15) 56 (15) 60 (17) 61 (9) 59
Risk factors for venous thromboembolism, n (%) 47 (53) 30 (55) 11 (53) 6 (54)
Progressive cancer 6 (8) 3 (5) 2 (10) 1 (10)
Thrombophiliaa 7 (8) 5 (9) 2 (10) 0
Recent surgery 16 (18) 10 (18) 4 (19) 2 (18)
Hospitalization 10 (11) 7 (13) 2 (10) 1 (10)
Other medical conditions 8 (9) 5 (9) 1 (5) 2 (18)
Clinical signs, n (%)
Dyspnoea 65 (74)
Tachycardia 31 (35)
Chest pain 28 (32)
Hypoxaemia 26 (30)
Hypotension 20 (22) 8 (15) 3 (14) 8 (72) 1
Syncope or lipothyma 18 (20) 11 (20) 4 (19) 3 (27)
Shock 15 (17) 6 (11) 2 (10) 6 (55) 1
Right heart failureb 10 (11)
Cyanosis 10 (11)
Auricular ﬁbrillation 9 (10)
Cardiac arrest 7 (8) 3 (5) 0 3 (27) 1
Haemoptysis 2 (2)
Paradoxical embolism, n (%) 39 (44) 24 (44) 12 (57) 3 (27) 0
Cerebral 26 (30) 14 (25) 11 (52) 1 (9)
Superior or inferior limb 13 (14) 10 (18) 1 (5) 2 (18)
Renal 3 (3) 3 (5) 0 0
Myocardial 3 (3) 1 (2) 2 (10) 0
Splenic 2 (2) 2 (4) 0 0
Multiple 8 (8) 6 (11) 2 (10) 0
Clinical presentation, n (%)
PE 83 (94) 51 (93) 20 (95) 11 (100) 1
Severe PE 30 (34) 17 (31) 4 (19) 8 (72) 1
PE and systemic embolism 36 (41) 23 (42) 10 (50) 3 (27)
Isolated systemic embolism 2 (2) 1 (2) 1 (5) 0
PE: pulmonary embolism; SD: standard deviation.
a History of thrombosis, lupus, protein S deﬁciency, antiphospholipid syndrome.
b Hepatojugular reﬂux, jugular vein turgescence.
642 E. Fauveau et al.
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pigure 5. Proportion of different treatment and outcome in
evere PE n = 30.
ulmonary thrombectomy was performed and in one case,
ulmonary thrombo-aspiration was performed. The size of
he thrombus was reported in 31 cases: it measured on aver-
ge 13± 7.5 cm. The longest thrombus measured 41 cm [7].
Clinical outcomes according to type of treatment
re reported in Table 2. Patients treated with hep-
rin and thrombolysis were older (60± 17 years and
1± 9 years, respectively) than those treated with surgery
56± 15 years). The group treated with heparin had more
requent stroke. Among the 30 patients with severe PE for
hom treatment data were reported, the proportion of hep-
rin and thrombolysis treatments was reversed (Fig. 5).
Most authors chose surgical treatment as the ﬁrst option.
en authors explained why they choose anticoagulant treat-
ent; they preferred this treatment because of important
ssociated comorbidities including advanced age, progres-
ive cancer, stroke and haemodynamic instability. One
uthor [37] choose this treatment as the ﬁrst option, argu-
ng that the embolic risk was weak based on the echographic
spect of the thrombus, which was described as small and
mmobile. One author selected this treatment in a young
atient without comorbidities [31], and chose to reserve
urgery or thrombolysis as the second option. The TSFO of
his patient measured 4 cm on TEE. Our two cases, treated
y heparin only, presented small TSFO and had favourable
utcomes. Authors’ arguments for using thrombolysis were
he presence of unstable haemodynamics and comorbidi-
ies. Two patients [4,38] had a paradoxical embolism after
iagnosis of TSFO. The ﬁrst received systemic urokinase
ssociated with a bolus of 1,000,000 IU injected into the
ight cardiac cavities through a Swan-Ganz probe. The
atient presented sudden ischaemia of the right upper limb.
he second patient presented an arterial embolism of the
eft lower limb, whereas he was treated with heparin in
n attempt at surgical embolectomy. He was then treated
ith thrombolysis. One patient presented a cerebral haem-
rrhage [18] after thrombolytic treatment.
Thrombus-monitoring echocardiography was speciﬁed for
1 of the 21 patients treated with heparin. TSFO disappeared
fter a mean of 12 days (range 4 days to 6weeks) without
linical embolic events. After thrombolysis in the survivor
opulation, the thrombus disappeared within 4 h to 6 days.
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Total mortality was 16% (14/88), 7/55 in the surgical
group, 3/21 in heparin-treated patients and 4/11 in patients
who received thrombolysis. For patients who presented with
severe PE (shock, cardiac arrest, collapse and syncope),
total mortality was higher (13/30) and was similar regard-
less of treatment choice with 7/17, 2/4 and 4/8 deaths in
the surgical, heparin and thrombolytic treatment groups,
respectively, and survival of the patient treated by isolated
vena cava ﬁlter (Table 2).
Discussion
This review of all published cases of TSFO provides insights
into the clinical context of TSFO occurrence.
We report, along with four new cases, the largest series
of TSFO ever published. The ﬁrst TSFO diagnosed by echocar-
diography was reported in 1985; the authors believed that
progress involving echocardiography would make TSFO a fre-
quent diagnosis but it remains uncommon.
Our review conﬁrms the association between TSFO and
thromboembolic disease, and frequently with severe PE,
as describe with right-sided heart thrombus [39]. Severe
PE, with increased pulmonary and right ventricle pressures,
could support clot migration across the PFO, by interauric-
ular pressure gradient reversal.
The frequent association of TSFO with paradoxical
embolism is also interesting, and in particular the fre-
quent cerebral site of embolism. It encourages most
authors to start aggressive treatment to prevent cerebral
embolism.
Echocardiography is essential for diagnosing TSFO
because it has been the only way, until now, to diagnose this
condition. We must highlight the essential role of TEE. Often
TSFO is not visualized by TTE, which means that TEE must be
performed as an emergency, when intracardiac mass is diag-
nosed or severe PE or thromboembolic disease associated
with systemic embolism with the suspicion of paradoxical
embolism. Indeed, the description of TSFO could change the
therapeutic approach.
The original ﬁnding from our study is the frequent use
of medical treatment with heparin and the favourable
outcome in this group of patients. Theoretically thrombol-
ysis or anticoagulation appears hazardous and the risk of
paradoxical embolism encourages most authors to be more
aggressive in their treatment strategy. However, in this
review there is only a slight difference in the mortality rates
after heparin or surgical treatment. Patients treated by
thrombolysis have a higher mortality but they have greater
hemodynamic compromise, which explains this mortality
difference. Indeed, if we compare patients with severe
PE, mortality is similar, independent of treatment used.
It appears that mortality is linked more to the severity of
clinical presentation than to the type of treatment. The
risk of paradoxical embolism is very difﬁcult to predict. In
this review paradoxical embolism after TSFO diagnosis was
reported in only two patients. It seems that whereas the
risk of systemic embolism is important before treatment,
it is decreased with anticoagulant treatment. In echocar-
diography monitoring the thrombus was still present after
several days, and even after it had disappeared it tended
to not to be associated with clinical embolism. The risk oft foramen ovale 643
hrombolysis to fragment the clot and induce paradoxical
mbolism is often cited by authors. The size of the TSFO
eems to be another important point for embolic risk.
Based on this review, anticoagulant treatment appears
o be an acceptable therapeutic alternative to surgery,
articularly in patients with comorbidities (e.g., increased
ge, stroke, progressive cancer) who are at high surgi-
al risk, and for patients with small TSFO. It is difﬁcult,
owever, to provide recommendations for the management
f patients presenting with TSFO because of the method-
logical limitations of our study. The data are based on a
ompilation of individual published cases, and are there-
ore subject to important bias. The heterogeneity and the
robability of unpublished cases are responsible for the
ack of information. Another limitation concerns patients
ho received multiple treatments. We took into account
he last treatment patients received. Because of these
ethodological limitations, we did not make any statisti-
al comparisons between the groups. However, we used this
pproach because of the paucity of published reports on
SFO.
onclusions
SFO is a complication of severe thromboembolic disease,
ith the migration of thrombus in left-heart cavities in
avour of pulmonary hypertension. It is frequently responsi-
le for paradoxical embolism before it has been diagnosed.
iagnosis is easy using echocardiography but it is often nec-
ssary to complete TTE with TEE to show it clearly. TEE
s justiﬁed in the case of intracardiac mass, severe PE and
uspicion of paradoxical embolism.
Thrombectomy under extracorporeal circulation is the
ost frequently chosen treatment in the published litera-
ure. Patients treated with heparin were older and more
ikely to have had a stroke or to have comorbidities than
perated patients. Thrombolysis is reserved for patients
ith severe PE and an unstable status, who cannot wait for
urgery.
There was a very slight difference in mortality between
atients treated with heparin and the surgical group. How-
ver, surgical treatment appears justiﬁed in the prevention
f paradoxical embolism, and must be done without delay
f it is the preferred treatment strategy. Heparin appears to
e an acceptable alternative. Thrombolysis is linked to the
ighest mortality, which could be explained by the severity
f the patient’s initial presentation.
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